StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Shanghai Stock Exchange:603392.SS
Sector
Location
Market Cap
USD 10.32 B
Share Price
USD 8.20
Avg Daily Volume
4,451,243
Change (1 day)
-1.20%
Change (1 year)
-9.93%
Change (YTD)
-15.05%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 48.63 M
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow is USD 48.63 M for the year ending December 31, 2024, a -77.55% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 216.60 M, a -63.83% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 598.85 M, a 126.23% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 264.70 M, a 269.03% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 71.73 M, a 83.18% change year over year.
Competitors
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Moderna, Inc.
USD 32.87
MRNA
-0.77
-2.29%
Swedish Orphan Biovitrum AB (publ)
USD 30.60
SOBI.ST
+0.82
2.76%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.83
300122.SZ
-0.03
-1.09%
Ionis Pharmaceuticals, Inc.
USD 42.55
IONS
+0.82
1.97%
Rhythm Pharmaceuticals, Inc.
USD 89.15
RYTM
+2.45
2.83%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.01
-0.39%
Vaxcyte, Inc.
USD 36.38
PCVX
+0.45
1.25%
Hualan Biological Engineering Inc.
USD 2.24
002007.SZ
+0.02
0.73%
Apellis Pharmaceuticals, Inc.
USD 19.91
APLS
+0.47
2.42%
NewAmsterdam Pharma Company N.V.
USD 22.17
NAMS
+0.63
2.93%
Ligand Pharmaceuticals Incorporated
USD 126.92
LGND
+5.22
4.29%
Apogee Therapeutics, Inc.
USD 38.88
APGE
+0.74
1.94%
Bavarian Nordic A/S
USD 28.18
BAVA.CO
-0.07
-0.24%
Adaptive Biotechnologies Corporation
USD 11.55
ADPT
-0.27
-2.28%
Immunocore Holdings plc
USD 35.30
IMCR
+0.28
0.80%
ARS Pharmaceuticals, Inc.
USD 17.90
SPRY
+0.21
1.19%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Moderna, Inc.
USD 32.87
MRNA
-0.77
-2.29%
Swedish Orphan Biovitrum AB (publ)
USD 30.60
SOBI.ST
+0.82
2.76%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.83
300122.SZ
-0.03
-1.09%
Ionis Pharmaceuticals, Inc.
USD 42.55
IONS
+0.82
1.97%
Rhythm Pharmaceuticals, Inc.
USD 89.15
RYTM
+2.45
2.83%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.01
-0.39%
Vaxcyte, Inc.
USD 36.38
PCVX
+0.45
1.25%
Hualan Biological Engineering Inc.
USD 2.24
002007.SZ
+0.02
0.73%
Apellis Pharmaceuticals, Inc.
USD 19.91
APLS
+0.47
2.42%
NewAmsterdam Pharma Company N.V.
USD 22.17
NAMS
+0.63
2.93%
Ligand Pharmaceuticals Incorporated
USD 126.92
LGND
+5.22
4.29%
Apogee Therapeutics, Inc.
USD 38.88
APGE
+0.74
1.94%
Bavarian Nordic A/S
USD 28.18
BAVA.CO
-0.07
-0.24%
Adaptive Biotechnologies Corporation
USD 11.55
ADPT
-0.27
-2.28%
Immunocore Holdings plc
USD 35.30
IMCR
+0.28
0.80%
ARS Pharmaceuticals, Inc.
USD 17.90
SPRY
+0.21
1.19%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%